Pediarix® DTaP, Hepatitis B, and Polio Vaccine Indicated for People 6 Weeks Through 6 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Hepatitis B (Recombinant) / Inactivated Poliovirus Vaccine Injection Prefilled Syringe 0.5 mL

Compare

McKesson #

742799

Manufacturer #

58160081152

Brand

Pediarix®

Manufacturer

Glaxo Smith Kline

Country of Origin

Unknown

Application

DTaP, Hepatitis B, and Polio Vaccine

Container Type

Prefilled Syringe

Dosage Form

Injection

Generic Drug Code

98511

Generic Drug Name

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Hepatitis B (Recombinant) / Inactivated Poliovirus Vaccine

NDC Number

58160081152

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

25 Lf - 10 Lf - 25 mcg - 10 mcg - 80 DU / 0.5 mL

Type

Intramuscular

UNSPSC Code

51202100

User

Indicated for People 6 Weeks Through 6 Years of Age

Volume

0.5 mL

PEDIARIX® is indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis
Each 0.5-mL dose is formulated to contain 25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated pertussis toxin (PT), 25 mcg of filamentous hemagglutinin (FHA), 8 mcg of pertactin (69 kiloDalton outer membrane protein), 10 mcg of HBsAg, 40 D-antigen Units (DU) of Type 1 poliovirus (Mahoney), 8 DU of Type 2 poliovirus (MEF-1), and 32 DU of Type 3 poliovirus (Saukett)
Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
Prefilled Tip Lok® Syringe